Semaglutide, suicidal ideation and behaviour: a resting state functional magnetic resonance imaging perspective - Verovnik B, Vovk A.
In recent months, there has been a lot of talk about the use of glucagon-like peptide 1 (GLP-1) receptor agonists, not only in type 2 diabetes but also for its effects on weight loss. Because of its wide use for this purpose and recent reports of suicidal ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
More News: Depression | Diabetes | Diabetes Type 2 | Endocrinology | International Medicine & Public Health | MRI Scan | Physiology | Suicide | Weight Loss